Elder Project Ltd vs TORRENT PHARMACEUTICALS L
A side-by-side comparison of Elder Project Ltd (524788) and TORRENT PHARMACEUTICALS L (TORNTPHARM) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, TORRENT PHARMACEUTICALS L leads 524788 vs TORNTPHARM on 10 of 14 metrics (1 tied). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
Valuation
How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
How efficiently each company turns capital and sales into profit. Higher is better.
Growth
Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has reduced debt.", "Debtor days have improved from 49.6 to 28.0 days."]
- − ["Company has low interest coverage ratio.", "The company has delivered a poor sales growth of 5.54% over past five years.", "Company has a low return on equity of -11.3% over last 3 years.", "Earnings include an other income of Rs.1.63 Cr.", "Company's cost of borrowing seems high"]
- + ["Company has a good return on equity (ROE) track record: 3 Years ROE 26.2%", "Company has been maintaining a healthy dividend payout of 57.8%"]
- − ["Stock is trading at 19.8 times its book value", "The company has delivered a poor sales growth of 11.8% over past five years.", "Company might be capitalizing the interest cost"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.